Literature DB >> 15463902

Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.

Silvia Campana1, Giovanni Taccetti, Novella Ravenni, Isabella Masi, Sandra Audino, Barbara Sisi, Teresa Repetto, Gerd Döring, Maurizio de Martino.   

Abstract

Chronic pulmonary infections caused by Pseudomonas aeruginosa, Burkholderia cepacia complex and Staphylococcus aureus are responsible for most of the morbidity and mortality of patients with cystic fibrosis (CF). Little is known about the routes of transmission of these pathogens from environmental or hospital sources to the patients. We hypothesised that strains of P. aeruginosa, B. cepacia complex and methicillin-resistant S. aureus (MRSA) are nosocomially acquired by CF patients. Bacterial isolates were obtained from 164 patients attending the CF Centre of Florence and from the hospital environment and the strains typed using restriction enzymes and pulsed-field gel electrophoresis (PFGE). Seventy (43%) of patients were colonised by P. aeruginosa, 6 (3.6%) by B. cepacia complex, and 11 (7%) by MRSA. Three P. aeruginosa strains were isolated from the sinks of the ward. All the MRSA isolates differed from each other. The analysis of 83 P. aeruginosa strains showed identical genotypes in five pairs of patients, whereas from the six patients infected with B. cepacia complex strains, two patients harboured identical genotypes. These pairs of patients had no contact with each other outside the CF centre and P. aeruginosa genotypes from the hospital environment differed from these clinical isolates, suggesting a possible common source of infection within or outside the centre. The study showed that, despite isolation precautions, a minimal risk of cross-infection still existed in the CF centre and that hygienic standards should be increased to further reduce this risk.

Entities:  

Mesh:

Year:  2004        PMID: 15463902     DOI: 10.1016/j.jcf.2004.03.010

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  11 in total

1.  ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Isabelle Vallet-Gely; Simon L Dove; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

2.  In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.

Authors:  Shinobu Takeda; Toru Nakai; Yoshimi Wakai; Fumiaki Ikeda; Kazuo Hatano
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.

Authors:  V Cafiso; T Bertuccio; D Spina; F Campanile; D Bongiorno; M Santagati; A Sciacca; C Sciuto; S Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-04       Impact factor: 3.267

Review 4.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

Review 5.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

Review 6.  Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.

Authors:  Sophie Moreau-Marquis; Bruce A Stanton; George A O'Toole
Journal:  Pulm Pharmacol Ther       Date:  2008-01-29       Impact factor: 3.410

7.  Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients.

Authors:  Hoang Vu-Thien; Gaëlle Corbineau; Katia Hormigos; Brigitte Fauroux; Harriet Corvol; Annick Clément; Gilles Vergnaud; Christine Pourcel
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

8.  Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients.

Authors:  L Spicuzza; C Sciuto; G Vitaliti; G Di Dio; S Leonardi; M La Rosa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-29       Impact factor: 3.267

9.  Structural stability of Burkholderia cenocepacia biofilms is reliant on eDNA structure and presence of a bacterial nucleic acid binding protein.

Authors:  Laura A Novotny; Amal O Amer; M Elizabeth Brockson; Steven D Goodman; Lauren O Bakaletz
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis.

Authors:  Harry S Porterfield; Lucas J Maakestad; Mason M LaMarche; Andrew L Thurman; Zoe E Kienenberger; Nicholas J Pitcher; Alexis R Hansen; Christian F Zirbes; Linda Boyken; Bethany L Muyskens; Alejandro A Pezzulo; Sachinkumar B Singh; Erik Twait; Bradley Ford; Daniel J Diekema; Valérie Reeb; Anthony J Fischer
Journal:  Pediatr Pulmonol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.